PainRelief.com Interview with:
Amani Meaidi, Postdoc, MD, Ph.D.
Danish Cancer Society
Danish Cancer Society Research Center
Copenhagen

PainRelief.com: What is the background for this study?

Response: Use of birth control formulations containing estrogen (combined hormonal contraception) is an acknowledged risk factor for venous thromboembolism.

NSAID use has also been shown to increase risk of thrombosis

NSAID use is likely to be the most common co-medication to hormonal contraception use – still, no study has looked at the effect of concomitant use of hormonal contraception and NSAID on venous thromboembolic risk.

Thus, we decided to study the thrombosis safety of using hormonal contraception and NSAIDs simultaneously.